Literature DB >> 13022862

Tuberculosis induced by droplet nuclei infection; initial homogeneous response of small mammals (rats, mice, guinea pigs, and hamsters) to human and to bovine bacilli, and the rate and pattern of tubercle development.

H L RATCLIFFE, V S PALLADINO.   

Abstract

Separate groups of rats, mice, hamsters, and guinea pigs were caused to inhale virulent tubercle bacilli, of human or bovine strains, as single cells in fine droplet nuclei. Members of each of these eight host-parasite combinations were killed for study at stated intervals after infection. For approximately 3 weeks after the bacilli were deposited in the lungs the progress of the infection, and the reaction of all species to it, followed a highly uniform developmental pattern. During the 4th week the rate and pattern of tubercle formation became distinctive for the species of host and the strain of parasite, but within any host-parasite combination this rate and pattern continued uniform for a time. The duration of this period of homogeneous response after the 4th week varied with the host-parasite combination, ranging from less than 5 weeks to more than 12 weeks after the induction of infection. It is concluded that the highly uniform initial response is evidence that these animals do not differ in their inherent resistance to inhaled infection by the bacilli of human or bovine tuberculosis. Instead, they differ widely in their capacity to acquire resistance to these organisms, as shown by the variation in the later stages of the disease.

Entities:  

Keywords:  TUBERCULOSIS, PULMONARY/experimental

Mesh:

Year:  1953        PMID: 13022862      PMCID: PMC2136179          DOI: 10.1084/jem.97.1.61

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  10 in total

1.  Bacteriologic procedures in sanitary air analysis: With special reference to air disinfection.

Authors:  W F Wells
Journal:  J Bacteriol       Date:  1943-12       Impact factor: 3.490

2.  Tuberculosis induced by droplet nuclei infection; pulmonary tuberculosis of predetermined initial intensity in mammals.

Authors:  H L RATCLIFFE
Journal:  Am J Hyg       Date:  1952-01

3.  The role of particle size in experimental air-borne infection.

Authors:  L S SONKIN
Journal:  Am J Hyg       Date:  1951-05

4.  Incidence of pulmonary tuberculosis among employees of tuberculosis hospitals.

Authors:  E X MIKOL; R HORTON; N S LINCOLN; A M STOKES
Journal:  Am Rev Tuberc       Date:  1952-07

5.  AN APPARATUS FOR THE STUDY OF EXPERIMENTAL AIR-BORNE DISEASE.

Authors:  W F Wells
Journal:  Science       Date:  1940-02-16       Impact factor: 47.728

6.  A Method for Obtaining Standard Suspensions of Tubercle Bacilli in the Form of Single Cells.

Authors:  W F Wells
Journal:  Science       Date:  1946-09-13       Impact factor: 47.728

7.  On the response of genetically resistant and susceptible rabbits to the quantitative inhalation of human type tubercle bacilli and the nature of resistance to tuberculosis.

Authors:  M B LURIE; S ABRAMSON; A G HEPPLESTON
Journal:  J Exp Med       Date:  1952-02       Impact factor: 14.307

8.  The effect of spermine on tubercle bacilli.

Authors:  J G HIRSCH; R J DUBOS
Journal:  J Exp Med       Date:  1952-02       Impact factor: 14.307

9.  Tuberculosis of rabbits induced by droplet nuclei infection; response to reinfection.

Authors:  H L RATCLIFFE; W F WELLS
Journal:  J Exp Med       Date:  1948-06-01       Impact factor: 14.307

10.  Tuberculosis of rabbits induced by droplet nuclei infection; initial response to infection.

Authors:  H L RATCLIFFE; W F WELLS
Journal:  J Exp Med       Date:  1948-06-01       Impact factor: 14.307

  10 in total
  13 in total

1.  Allergy in experimental rat tuberculosis.

Authors:  D F GRAY; J L NOBLE; M O'HARA
Journal:  J Hyg (Lond)       Date:  1961-12

2.  The relative natural resistance of rats and mice to experimental pulmonary tuberculosis.

Authors:  D F GRAY
Journal:  J Hyg (Lond)       Date:  1961-12

3.  Variations in natural resistance to tuberculosis.

Authors:  D F GRAY; H GRAHAM-SMITH; J L NOBLE
Journal:  J Hyg (Lond)       Date:  1960-06

4.  Tuberculosis induced by droplet nuclei infection; its developmental pattern in guinea pigs and rats in relation to dietary protein.

Authors:  H L RATCLIFFE; J V MERRICK
Journal:  Am J Pathol       Date:  1957 Nov-Dec       Impact factor: 4.307

5.  Tuberculosis induced by droplet nuclei infection; its developmental pattern in hamsters in relation to levels of dietary protein.

Authors:  J V MERRICK; H L RATCLIFFE
Journal:  Am J Pathol       Date:  1957 Jan-Feb       Impact factor: 4.307

6.  Pulmonary lymphatics are primary sites of Mycobacterium tuberculosis infection in guinea pigs infected by aerosol.

Authors:  Randall J Basaraba; Erin E Smith; Crystal A Shanley; Ian M Orme
Journal:  Infect Immun       Date:  2006-09       Impact factor: 3.441

7.  Adjuvant modulation of the cytokine balance in Mycobacterium tuberculosis subunit vaccines; immunity, pathology and protection.

Authors:  Else Marie Agger; Joseph P Cassidy; Joseph Brady; Karen S Korsholm; Carina Vingsbo-Lundberg; Peter Andersen
Journal:  Immunology       Date:  2008-01-12       Impact factor: 7.397

8.  Immune response to Mycobacterium tuberculosis in rats.

Authors:  M J Lefford; D D McGregor; G B Mackaness
Journal:  Infect Immun       Date:  1973-08       Impact factor: 3.441

9.  Vaccination of guinea pigs with DNA encoding the mycobacterial antigen MPB83 influences pulmonary pathology but not hematogenous spread following aerogenic infection with Mycobacterium bovis.

Authors:  Mark A Chambers; Ann Williams; Graham Hatch; Dolores Gavier-Widén; Graham Hall; Kris Huygen; Douglas Lowrie; Philip D Marsh; R Glyn Hewinson
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

10.  Cellular reaction in the footpad and draining lymph nodes of mice induced by mycobacterial fractions and BCG bacilli.

Authors:  A Bekierkunst; I S Levij; E Yarkoni; E Vilkas; E Lederer
Journal:  Infect Immun       Date:  1971-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.